Epoetin beta for the treatment of chemotherapy-induced anemia: an update

Abstract

Epoetin beta belongs to the class of erythropoiesis-stimulating agents (ESAs) that are currently available to treat anemic patients receiving chemotherapy. Chemotherapy-induced anemia affects a high percentage of cancer patients and, due to its negative effects on disease outcome and the patient's quality of life, should be treated when first diagnosed… (More)
DOI: 10.2147/OTT.S77497

Topics

6 Figures and Tables

Cite this paper

@inproceedings{Galli2015EpoetinBF, title={Epoetin beta for the treatment of chemotherapy-induced anemia: an update}, author={L. Galli and Clara Ricci and Colin Gerard Egan}, booktitle={OncoTargets and therapy}, year={2015} }